# Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients

> **NCT02461602** · — · COMPLETED · sponsor: **Duke University** · enrollment: 251 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02461602
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2018-05-31
- **Final completion:** 2018-05-31
- **Target enrollment:** 251 (ACTUAL)
- **Last updated:** 2019-04-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02461602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02461602, "Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02461602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*